RENA KAVIAN

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant BROOKLYN, NY NPI 1922439744

General Payments — all program years on this page

$2,252.82

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 95
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $651.50 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $651.5021

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $387.2520
2022 $479.9325
2023 $734.1429
2024 $651.5021

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086978428 Novartis Pharmaceuticals Corporation $28.97 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086978432 Novartis Pharmaceuticals Corporation $15.19 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086978448 Novartis Pharmaceuticals Corporation $27.64 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105223172 AstraZeneca Pharmaceuticals LP $18.28 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105567282 AstraZeneca Pharmaceuticals LP $125.00 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113473451 Kowa Pharmaceuticals America, Inc. $21.97 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114729251 Exact Sciences Corporation $16.40 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114729257 Exact Sciences Corporation $20.60 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116270201 GlaxoSmithKline, LLC. $21.12 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119109607 Otsuka America Pharmaceutical, Inc. $18.54 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119109609 Otsuka America Pharmaceutical, Inc. $25.16 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119109611 Otsuka America Pharmaceutical, Inc. $24.38 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119109613 Otsuka America Pharmaceutical, Inc. $24.21 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131489532 PFIZER INC. $16.76 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135929494 Lilly USA, LLC $18.42 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135929496 Lilly USA, LLC $125.00 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135929498 Lilly USA, LLC $20.90 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141739839 Merck Sharp & Dohme LLC $22.53 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141938755 Merck Sharp & Dohme LLC $17.08 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146732660 Ardelyx, Inc. $20.30 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146732662 Ardelyx, Inc. $23.05 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.